Honest Criticisms and Limitations of the KEEPS Trial
A deep-dive into the enrollment biases, follow-up gaps, statistical caveats, and generalizability concerns that limit interpretation of the KEEPS hormone therapy trial.
Read clinical reviewTopic Hub
5 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.
Explore
Showing 5 of 5 clinical reviews.
A deep-dive into the enrollment biases, follow-up gaps, statistical caveats, and generalizability concerns that limit interpretation of the KEEPS hormone therapy trial.
Read clinical reviewA deep-dive into the KEEPS trial design, randomization, blinding, endpoint definitions, and statistical choices that shape how early HRT timing results should be interpreted.
Read clinical reviewWhat the KEEPS trial follow-up revealed about long-term HRT safety, durability of cardiovascular and cognitive outcomes, and the timing hypothesis in early menopause.
Read clinical reviewDetailed breakdown of KEEPS trial pre-specified and post-hoc subgroup analyses examining which early postmenopausal women benefited most from oral CEE or transdermal estradiol on carotid IMT, mood, cognition, and cardiometabolic markers.
Read clinical reviewA deep-dive into the KEEPS trial's real-world clinical implications for early postmenopausal HRT prescribing, guideline updates, and patient selection beyond the original study population.
Read clinical review